Advertisement

Sudden blindness and deafness disclosing meningeal carcinomatosis in non-small cell lung cancer

  • Guillaume Costentin
  • C. Richard
  • A. Rouille
  • B. Bourre
  • R. Lefaucheur
  • L. Grangeon
Letter to the Editor
  • 6 Downloads

Case report

A 63-year-old woman was admitted for acute right-sided hearing loss and acute dizziness, initially diagnosed as vestibular neuritis. She had no medical history except active smoking. Neurological examination was normal. Hearing loss progressively worsened over the week after, becoming bilateral and leading to complete deafness. Repeated clinical examination showed a right peripheral facial palsy and pyramidal syndrome with bilateral Babinski’s sign. She had no fever and was not confused. There were no B-symptoms or respiratory complaints. Blood cell count and C-reactive protein were normal. Brain CT scan was normal. CSF analysis disclosed 38 leukocytes/µL (N < 5 leukocytes/µL), 400 red blood cells/µL (N < 5/µL), a protein level of 1.0 g/L (N < 0.40 g/L), and a glucose level of 0.4 g/L (N = 0.5–0.8 g/L). Cytology analysis identified malignant cells with positive TTF1 and CK7 immunostaining, which strongly supported the diagnosis of meningeal carcinomatosis (MC) associated...

Keywords

Meningeal carcinomatosis Blindness Deafness Non-small cell lung cancer 

Notes

Author contributions

GC: acquisition of data, analysis, interpretation, critical revision of the manuscript for important intellectual content, and study supervision. CR: acquisition of data, analysis, and interpretation. AR: acquisition of data, analysis, and interpretation. BB: acquisition of data, analysis, and interpretation. RL: acquisition of data, analysis, interpretation, and critical revision of the manuscript for important intellectual content. LG: acquisition of data, analysis, interpretation, and critical revision of the manuscript for important intellectual content.

Funding

No funding was received.

Compliance with ethical standards

Conflict of interest

Guillaume Costentin reports no financial disclosures. Clément Richard reports no financial disclosures. Audrey Rouillé reports no financial disclosures. Bertrand Bourre reports no financial disclosures. Romain Lefaucheur reports no financial disclosures. Lou Grangeon reports no financial disclosures.

Research involving human and animals participants

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Kountourakis P, Ardavanis A (2010) Visual and hearing loss due to colorectal MC: a case-based review. Clin Adv Hematol Oncol 8(8):567–568Google Scholar
  2. 2.
    Bruce BB, Tehrani M, Newman NJ, Biousse V (2010) Deafness and blindness as a presentation of colorectal meningeal carcinomatosis. Clin Adv Hematol Oncol 8(8):564–566Google Scholar
  3. 3.
    Liu J, Jia H, Yang Y, Dai W, Su X, Zhao G (2009) Cerebrospinal fluid cytology and clinical analysis of 34 cases with leptoMC. J Int Med Res 37(6):1913–1920CrossRefGoogle Scholar
  4. 4.
    Glantz MJ, Cole BF, Glantz LK et al (1998) Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 82(4):733–739CrossRefGoogle Scholar
  5. 5.
    Lee SJ, Lee JI, Nam DH, Ahn YC, Han JH, Sun JM, Ahn JS, Park K, Ahn MJ (2013) LeptoMC in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. J Thorac Oncol 8(2):185–191CrossRefGoogle Scholar

Copyright information

© Belgian Neurological Society 2018

Authors and Affiliations

  1. 1.Department of NeurologyRouen University HospitalRouen CedexFrance

Personalised recommendations